South San Francisco, CA – According to filings with the U.S. Securities and Exchange Commission, Genome Medical is raising $14,999,998.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Lisa Alderson played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Genome Medical

We are a nationwide medical practice accelerating access to genetic specialists through a virtual care network and innovative patient-navigation technology. Genome Medical is the first and only nationwide telegenomics practice serving health systems, providers, employers and individuals. We deliver easy and seamless genetic expertise in the following areas of clinical care: cancer, cardio, proactive health, reproductive health, pediatric, and pharmacy.

To learn more about Genome Medical, visit http://www.genomemedical.com/

Contact:
Lisa Alderson, Chief Executive Officer
877-688-0992
lisa@genomemedical.com
https://www.linkedin.com/in/lalderson/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved